Healthcare Industry News: joint replacement
News Release - August 4, 2006
Biomet Retains Heidrick & Struggles and The McLoughlin Company to Assist in CEO SearchWARSAW, Ind.--(HSMN NewsFeed)--Aug. 4, 2006--Biomet Inc. (NASDAQ:BMET ) today announced that it has retained the services of Heidrick & Struggles, one of the world's premier executive search and leadership consulting firms, and The McLoughlin Company, an advisor on institutional management, to conduct a global search for candidates to serve as Biomet's President and Chief Executive Officer. Dane A. Miller, PhD, resigned from the position of President and CEO on March 27, 2006, at which time Daniel P. Hann assumed the role of Interim President and CEO.
The Board of Directors will carefully consider both internal and external candidates in its search for a new President and CEO. It is pleased to partner with respected, top-level firms like Heidrick & Struggles and The McLoughlin Company. Their use of best management practices, their global reach and depth of experience in the medical devices industry will help ensure a smooth transition to the next era of leadership.
Leading the search team from Heidrick & Struggles are William A. Matthews, Partner, Atlanta, and David L. Vied, Partner, Los Angeles. Paul McLoughlin represents The McLoughlin Company.
About Heidrick & Struggles International, Inc.
Heidrick & Struggles International, Inc. (NASDAQ:HSII ) is the world's premier provider of senior-level executive search and leadership consulting services, including talent management, board building, executive on-boarding and M&A effectiveness. For more than 50 years, the company has focused on quality service and built strong leadership teams through their relationships with clients and individuals worldwide. Today, their leadership experts operate from principal business centers in North America, Latin America, Europe and Asia Pacific. For more information about Heidrick & Struggles, visit www.heidrick.com.
About The McLoughlin Company
The McLoughlin Company is a sole proprietorship providing a broad range of advisory services to boards, CEOs and senior executive teams at corporations, not-for-profit institutions, and financial service firms with focus on senior management, marketing, and technology. For more information about The McLoughlin Company visit www.themcloughlincompany.com.
About Biomet, Inc.
Biomet, Inc. and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. The Company's product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in more than 100 countries.
Source: Biomet, Inc
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.